BACKGROUND: Recent meta-analyses show strong evidence of associations among genetic variants in CHRNA5 on chromosome 15q25, smoking quantity, and lung cancer. This meta-analysis tests whether the CHRNA5 variant rs16969968 predicts age of smoking cessation and age of lung cancer diagnosis. METHODS: Meta-analyses examined associations between rs16969968, age of quitting smoking, and age of lung cancer diagnosis in 24 studies of European ancestry (n = 29 072). In each dataset, we used Cox regression models to evaluate the association between rs16969968 and the two primary phenotypes (age of smoking cessation among ever smokers and age of lung cancer diagnosis among lung cancer case patients) and the secondary phenotype of smoking duration. Heterogeneity across studies was assessed with the Cochran Q test. All statistical tests were two-sided. RESULTS: The rs16969968 allele (A) was associated with a lower likelihood of smoking cessation (hazard ratio [HR] = 0.95, 95% confidence interval [CI] = 0.91 to 0.98, P = .0042), and the AA genotype was associated with a four-year delay in median age of quitting compared with the GG genotype. Among smokers with lung cancer diagnoses, the rs16969968 genotype (AA) was associated with a four-year earlier median age of diagnosis compared with the low-risk genotype (GG) (HR = 1.08, 95% CI = 1.04 to 1.12, P = 1.1*10(-5)). CONCLUSION: These data support the clinical significance of the CHRNA5 variant rs16969968. It predicts delayed smoking cessation and an earlier age of lung cancer diagnosis in this meta-analysis. Given the existing evidence that this CHRNA5 variant predicts favorable response to cessation pharmacotherapy, these findings underscore the potential clinical and public health importance of rs16969968 in CHRNA5 in relation to smoking cessation success and lung cancer risk.
BACKGROUND: Recent meta-analyses show strong evidence of associations among genetic variants in CHRNA5 on chromosome 15q25, smoking quantity, and lung cancer. This meta-analysis tests whether the CHRNA5 variant rs16969968 predicts age of smoking cessation and age of lung cancer diagnosis. METHODS: Meta-analyses examined associations between rs16969968, age of quitting smoking, and age of lung cancer diagnosis in 24 studies of European ancestry (n = 29 072). In each dataset, we used Cox regression models to evaluate the association between rs16969968 and the two primary phenotypes (age of smoking cessation among ever smokers and age of lung cancer diagnosis among lung cancer case patients) and the secondary phenotype of smoking duration. Heterogeneity across studies was assessed with the Cochran Q test. All statistical tests were two-sided. RESULTS: The rs16969968 allele (A) was associated with a lower likelihood of smoking cessation (hazard ratio [HR] = 0.95, 95% confidence interval [CI] = 0.91 to 0.98, P = .0042), and the AA genotype was associated with a four-year delay in median age of quitting compared with the GG genotype. Among smokers with lung cancer diagnoses, the rs16969968 genotype (AA) was associated with a four-year earlier median age of diagnosis compared with the low-risk genotype (GG) (HR = 1.08, 95% CI = 1.04 to 1.12, P = 1.1*10(-5)). CONCLUSION: These data support the clinical significance of the CHRNA5 variant rs16969968. It predicts delayed smoking cessation and an earlier age of lung cancer diagnosis in this meta-analysis. Given the existing evidence that this CHRNA5 variant predicts favorable response to cessation pharmacotherapy, these findings underscore the potential clinical and public health importance of rs16969968 in CHRNA5 in relation to smoking cessation success and lung cancer risk.
Authors: Li-Shiun Chen; Timothy B Baker; Megan E Piper; Naomi Breslau; Dale S Cannon; Kimberly F Doheny; Stephanie M Gogarten; Eric O Johnson; Nancy L Saccone; Jen C Wang; Robert B Weiss; Alison M Goate; Laura Jean Bierut Journal: Am J Psychiatry Date: 2012-07 Impact factor: 18.112
Authors: Marcus R Munafò; Elaine C Johnstone; Donna Walther; George R Uhl; Michael F G Murphy; Paul Aveyard Journal: Nicotine Tob Res Date: 2011-06-20 Impact factor: 4.244
Authors: Jane E Sarginson; Joel D Killen; Laura C Lazzeroni; Stephen P Fortmann; Heather S Ryan; Alan F Schatzberg; Greer M Murphy Journal: Am J Med Genet B Neuropsychiatr Genet Date: 2011-01-25 Impact factor: 3.568
Authors: Andrew W Bergen; Harold S Javitz; Ruth Krasnow; Denise Nishita; Martha Michel; David V Conti; Jinghua Liu; Won Lee; Christopher K Edlund; Sharon Hall; Pui-Yan Kwok; Neal L Benowitz; Timothy B Baker; Rachel F Tyndale; Caryn Lerman; Gary E Swan Journal: Pharmacogenet Genomics Date: 2013-02 Impact factor: 2.089
Authors: Prabhat Jha; Chinthanie Ramasundarahettige; Victoria Landsman; Brian Rostron; Michael Thun; Robert N Anderson; Tim McAfee; Richard Peto Journal: N Engl J Med Date: 2013-01-24 Impact factor: 91.245
Authors: David P King; Sara Paciga; Eve Pickering; Neal L Benowitz; Laura J Bierut; David V Conti; Jaakko Kaprio; Caryn Lerman; Peter W Park Journal: Neuropsychopharmacology Date: 2011-11-02 Impact factor: 7.853
Authors: Sarah M Hartz; Susan E Short; Nancy L Saccone; Robert Culverhouse; LiShiun Chen; Tae-Hwi Schwantes-An; Hilary Coon; Younghun Han; Sarah H Stephens; Juzhong Sun; Xiangning Chen; Francesca Ducci; Nicole Dueker; Nora Franceschini; Josef Frank; Frank Geller; Daniel Gubjartsson; Nadia N Hansel; Chenhui Jiang; Kaisu Keskitalo-Vuokko; Zhen Liu; Leo-Pekka Lyytikäinen; Martha Michel; Rajesh Rawal; Albert Rosenberger; Paul Scheet; John R Shaffer; Alexander Teumer; John R Thompson; Jacqueline M Vink; Nicole Vogelzangs; Angela S Wenzlaff; William Wheeler; Xiangjun Xiao; Bao-Zhu Yang; Steven H Aggen; Anthony J Balmforth; Sebastian E Baumeister; Terri Beaty; Siiri Bennett; Andrew W Bergen; Heather A Boyd; Ulla Broms; Harry Campbell; Nilanjan Chatterjee; Jingchun Chen; Yu-Ching Cheng; Sven Cichon; David Couper; Francesco Cucca; Danielle M Dick; Tatiana Foroud; Helena Furberg; Ina Giegling; Fangyi Gu; Alistair S Hall; Jenni Hällfors; Shizhong Han; Annette M Hartmann; Caroline Hayward; Kauko Heikkilä; John K Hewitt; Jouke Jan Hottenga; Majken K Jensen; Pekka Jousilahti; Marika Kaakinen; Steven J Kittner; Bettina Konte; Tellervo Korhonen; Maria-Teresa Landi; Tiina Laatikainen; Mark Leppert; Steven M Levy; Rasika A Mathias; Daniel W McNeil; Sarah E Medland; Grant W Montgomery; Thomas Muley; Tanda Murray; Matthias Nauck; Kari North; Michele Pergadia; Ozren Polasek; Erin M Ramos; Samuli Ripatti; Angela Risch; Ingo Ruczinski; Igor Rudan; Veikko Salomaa; David Schlessinger; Unnur Styrkársdóttir; Antonio Terracciano; Manuela Uda; Gonneke Willemsen; Xifeng Wu; Goncalo Abecasis; Kathleen Barnes; Heike Bickeböller; Eric Boerwinkle; Dorret I Boomsma; Neil Caporaso; Jubao Duan; Howard J Edenberg; Clyde Francks; Pablo V Gejman; Joel Gelernter; Hans Jörgen Grabe; Hyman Hops; Marjo-Riitta Jarvelin; Jorma Viikari; Mika Kähönen; Kenneth S Kendler; Terho Lehtimäki; Douglas F Levinson; Mary L Marazita; Jonathan Marchini; Mads Melbye; Braxton D Mitchell; Jeffrey C Murray; Markus M Nöthen; Brenda W Penninx; Olli Raitakari; Marcella Rietschel; Dan Rujescu; Nilesh J Samani; Alan R Sanders; Ann G Schwartz; Sanjay Shete; Jianxin Shi; Margaret Spitz; Kari Stefansson; Gary E Swan; Thorgeir Thorgeirsson; Henry Völzke; Qingyi Wei; H-Erich Wichmann; Christopher I Amos; Naomi Breslau; Dale S Cannon; Marissa Ehringer; Richard Grucza; Dorothy Hatsukami; Andrew Heath; Eric O Johnson; Jaakko Kaprio; Pamela Madden; Nicholas G Martin; Victoria L Stevens; Jerry A Stitzel; Robert B Weiss; Peter Kraft; Laura J Bierut Journal: Arch Gen Psychiatry Date: 2012-08
Authors: G R Uhl; D Walther; R Musci; C Fisher; J C Anthony; C L Storr; F M Behm; W W Eaton; N Ialongo; J E Rose Journal: Mol Psychiatry Date: 2012-11-06 Impact factor: 15.992
Authors: Chirag J Patel; Jacqueline Kerr; Duncan C Thomas; Bhramar Mukherjee; Beate Ritz; Nilanjan Chatterjee; Marta Jankowska; Juliette Madan; Margaret R Karagas; Kimberly A McAllister; Leah E Mechanic; M Daniele Fallin; Christine Ladd-Acosta; Ian A Blair; Susan L Teitelbaum; Christopher I Amos Journal: Cancer Epidemiol Biomarkers Prev Date: 2017-07-14 Impact factor: 4.254
Authors: Li-Shiun Chen; Timothy B Baker; J Philip Miller; Michael Bray; Nina Smock; Jingling Chen; Faith Stoneking; Robert C Culverhouse; Nancy L Saccone; Christopher I Amos; Robert M Carney; Douglas E Jorenby; Laura J Bierut Journal: Clin Pharmacol Ther Date: 2020-08-04 Impact factor: 6.875
Authors: Nancy L Saccone; Leslie S Emery; Tamar Sofer; Stephanie M Gogarten; Diane M Becker; Erwin P Bottinger; Li-Shiun Chen; Robert C Culverhouse; Weimin Duan; Dana B Hancock; H Dean Hosgood; Eric O Johnson; Ruth J F Loos; Tin Louie; George Papanicolaou; Krista M Perreira; Erik J Rodriquez; Claudia Schurmann; Adrienne M Stilp; Adam A Szpiro; Gregory A Talavera; Kent D Taylor; James F Thrasher; Lisa R Yanek; Cathy C Laurie; Eliseo J Pérez-Stable; Laura J Bierut; Robert C Kaplan Journal: Nicotine Tob Res Date: 2018-03-06 Impact factor: 4.244
Authors: Alex T Ramsey; Li-Shiun Chen; Sarah M Hartz; Nancy L Saccone; Sherri L Fisher; Enola K Proctor; Laura J Bierut Journal: Transl Behav Med Date: 2018-01-29 Impact factor: 3.046